APO Research

APO RESEARCH · REPORT

Antigout Drug

Selected research

Industry Growth & Trends

Global Antigout Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Antigout Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antigout Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antigout Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antigout Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antigout Drug include Aspen, heumann pharma, Horizon Pharma, KPC Pharmaceuticals, Rotamreddy, WanBang, Teijin Pharma, Jiangsu Hengrui Medicine and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antigout Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antigout Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antigout Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antigout Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antigout Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antigout Drug Market by Company

Aspen

heumann pharma

Horizon Pharma

KPC Pharmaceuticals

Rotamreddy

WanBang

Teijin Pharma

Jiangsu Hengrui Medicine

Novartis

Takeda

Antigout Drug Segment by Type

Colchicine

Febuxostat

Allopurinol

Benzbromarone

Antigout Drug Segment by Application

Acute Gout

Chronic Gout

Antigout Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antigout Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antigout Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antigout Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antigout Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antigout Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Colchicine Table 2. Major Company of Febuxostat Table 3. Major Company of Allopurinol Table 4. Major Company of Benzbromarone Table 5. Global Antigout Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Antigout Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Antigout Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Antigout Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Antigout Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Antigout Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Antigout Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Antigout Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Antigout Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Antigout Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Antigout Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Antigout Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Antigout Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Antigout Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Antigout Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Antigout Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Antigout Drug Industry Trends Table 27. Antigout Drug Industry Drivers Table 28. Antigout Drug Industry Opportunities and Challenges Table 29. Antigout Drug Industry Restraints Table 30. Global Antigout Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Antigout Drug Revenue Market Share by Company (2021-2026) Table 32. Global Antigout Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Antigout Drug Sales Share by Company (2021-2026) Table 34. Global Antigout Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Antigout Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Antigout Drug Major Company Production Sites and Headquarters Table 37. Global Antigout Drug Company, Product Type & Application Table 38. Global Antigout Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Antigout Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Antigout Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Antigout Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Antigout Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Antigout Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Antigout Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Antigout Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Antigout Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Antigout Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Antigout Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Antigout Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Antigout Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Antigout Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Antigout Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Antigout Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Antigout Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Antigout Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Antigout Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Antigout Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Antigout Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Antigout Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Antigout Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Antigout Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Antigout Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Antigout Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Antigout Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Antigout Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Antigout Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Aspen Company Information Table 74. Aspen Business Overview Table 75. Aspen Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Aspen Antigout Drug Product Portfolio Table 77. Aspen Recent Development Table 78. heumann pharma Company Information Table 79. heumann pharma Business Overview Table 80. heumann pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. heumann pharma Antigout Drug Product Portfolio Table 82. heumann pharma Recent Development Table 83. Horizon Pharma Company Information Table 84. Horizon Pharma Business Overview Table 85. Horizon Pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Horizon Pharma Antigout Drug Product Portfolio Table 87. Horizon Pharma Recent Development Table 88. KPC Pharmaceuticals Company Information Table 89. KPC Pharmaceuticals Business Overview Table 90. KPC Pharmaceuticals Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. KPC Pharmaceuticals Antigout Drug Product Portfolio Table 92. KPC Pharmaceuticals Recent Development Table 93. Rotamreddy Company Information Table 94. Rotamreddy Business Overview Table 95. Rotamreddy Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Rotamreddy Antigout Drug Product Portfolio Table 97. Rotamreddy Recent Development Table 98. WanBang Company Information Table 99. WanBang Business Overview Table 100. WanBang Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. WanBang Antigout Drug Product Portfolio Table 102. WanBang Recent Development Table 103. Teijin Pharma Company Information Table 104. Teijin Pharma Business Overview Table 105. Teijin Pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Teijin Pharma Antigout Drug Product Portfolio Table 107. Teijin Pharma Recent Development Table 108. Jiangsu Hengrui Medicine Company Information Table 109. Jiangsu Hengrui Medicine Business Overview Table 110. Jiangsu Hengrui Medicine Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Jiangsu Hengrui Medicine Antigout Drug Product Portfolio Table 112. Jiangsu Hengrui Medicine Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Novartis Antigout Drug Product Portfolio Table 117. Novartis Recent Development Table 118. Takeda Company Information Table 119. Takeda Business Overview Table 120. Takeda Antigout Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Takeda Antigout Drug Product Portfolio Table 122. Takeda Recent Development Table 123. North America Antigout Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Antigout Drug Sales by Country (2021-2026) & (K Units) Table 125. North America Antigout Drug Sales Market Share by Country (2021-2026) Table 126. North America Antigout Drug Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Antigout Drug Sales Market Share Forecast by Country (2027-2032) Table 128. North America Antigout Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Antigout Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Antigout Drug Market Share by Country (2021-2026) Table 131. North America Antigout Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Antigout Drug Market Share Forecast by Country (2027-2032) Table 133. Europe Antigout Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Antigout Drug Sales by Country (2021-2026) & (K Units) Table 135. Europe Antigout Drug Sales Market Share by Country (2021-2026) Table 136. Europe Antigout Drug Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Antigout Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Antigout Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Antigout Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Antigout Drug Market Share by Country (2021-2026) Table 141. Europe Antigout Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Antigout Drug Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Antigout Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Antigout Drug Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Antigout Drug Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Antigout Drug Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Antigout Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Antigout Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Antigout Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Antigout Drug Market Share by Country (2021-2026) Table 151. Asia-Pacific Antigout Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Antigout Drug Market Share Forecast by Country (2027-2032) Table 153. Latin America Antigout Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Antigout Drug Sales by Country (2021-2026) & (K Units) Table 155. Latin America Antigout Drug Sales Market Share by Country (2021-2026) Table 156. Latin America Antigout Drug Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Antigout Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Antigout Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Antigout Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Antigout Drug Market Share by Country (2021-2026) Table 161. Latin America Antigout Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Antigout Drug Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Antigout Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Antigout Drug Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Antigout Drug Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Antigout Drug Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Antigout Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Antigout Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Antigout Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Antigout Drug Market Share by Country (2021-2026) Table 171. Middle East and Africa Antigout Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Antigout Drug Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Antigout Drug Distributors List Table 176. Antigout Drug Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Antigout Drug Image Figure 2. Global Antigout Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antigout Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Antigout Drug Sales (2021-2032) & (K Units) Figure 5. Colchicine Image Figure 6. Global Colchicine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Febuxostat Image Figure 8. Global Febuxostat Sales YoY Growth (2021-2032) & (K Units) Figure 9. Allopurinol Image Figure 10. Global Allopurinol Sales YoY Growth (2021-2032) & (K Units) Figure 11. Benzbromarone Image Figure 12. Global Benzbromarone Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Antigout Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Antigout Drug Market Share by Type 2025 VS 2032 Figure 15. North America Antigout Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Antigout Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Antigout Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Antigout Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Antigout Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Antigout Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Antigout Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Antigout Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Antigout Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Antigout Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Antigout Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Acute Gout Image Figure 28. Global Acute Gout Sales YoY Growth (2021-2032) & (K Units) Figure 29. Chronic Gout Image Figure 30. Global Chronic Gout Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Antigout Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antigout Drug Market Share by Application 2025 VS 2032 Figure 33. North America Antigout Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Antigout Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Antigout Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antigout Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antigout Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antigout Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antigout Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antigout Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antigout Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antigout Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Antigout Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Antigout Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antigout Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antigout Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antigout Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Antigout Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antigout Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antigout Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antigout Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Antigout Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antigout Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antigout Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antigout Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Antigout Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antigout Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antigout Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antigout Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Antigout Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antigout Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antigout Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antigout Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antigout Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Colchicine
  • Febuxostat
  • Allopurinol
  • Benzbromarone
Applications
  • Acute Gout
  • Chronic Gout
Companies covered
  • Aspen
  • heumann pharma
  • Horizon Pharma
  • KPC Pharmaceuticals
  • Rotamreddy
  • WanBang
  • Teijin Pharma
  • Jiangsu Hengrui Medicine
  • Novartis
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antigout Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antigout Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antigout Drug Market by Type
  6. 1.3.1 Colchicine
  7. 1.3.2 Febuxostat
  8. 1.3.3 Allopurinol
  9. 1.3.4 Benzbromarone
  10. 1.4 Global Antigout Drug Market Size by Type
  11. 1.4.1 Global Antigout Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Antigout Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Antigout Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Antigout Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Antigout Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Antigout Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Antigout Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Antigout Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antigout Drug Industry Trends
  2. 2.2 Antigout Drug Industry Drivers
  3. 2.3 Antigout Drug Industry Opportunities and Challenges
  4. 2.4 Antigout Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antigout Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Antigout Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Antigout Drug Price (2021-2026)
  4. 3.4 Global Antigout Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antigout Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Antigout Drug Company, Product Type & Application
  7. 3.7 Global Antigout Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antigout Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antigout Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antigout Drug Tier 1, Tier 2, and Tier 3
4 Antigout Drug Regional Status and Outlook
  1. 4.1 Global Antigout Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antigout Drug Historic Market Size by Region
  3. 4.2.1 Global Antigout Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antigout Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antigout Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antigout Drug Forecasted Market Size by Region
  7. 4.3.1 Global Antigout Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antigout Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antigout Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antigout Drug by Application
  1. 5.1 Antigout Drug Market by Application
  2. 5.1.1 Acute Gout
  3. 5.1.2 Chronic Gout
  4. 5.2 Global Antigout Drug Market Size by Application
  5. 5.2.1 Global Antigout Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antigout Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antigout Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antigout Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antigout Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antigout Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antigout Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antigout Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aspen
  2. 6.1.1 Aspen Company Information
  3. 6.1.2 Aspen Business Overview
  4. 6.1.3 Aspen Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aspen Antigout Drug Product Portfolio
  6. 6.1.5 Aspen Recent Developments
  7. 6.2 heumann pharma
  8. 6.2.1 heumann pharma Company Information
  9. 6.2.2 heumann pharma Business Overview
  10. 6.2.3 heumann pharma Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 heumann pharma Antigout Drug Product Portfolio
  12. 6.2.5 heumann pharma Recent Developments
  13. 6.3 Horizon Pharma
  14. 6.3.1 Horizon Pharma Company Information
  15. 6.3.2 Horizon Pharma Business Overview
  16. 6.3.3 Horizon Pharma Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Horizon Pharma Antigout Drug Product Portfolio
  18. 6.3.5 Horizon Pharma Recent Developments
  19. 6.4 KPC Pharmaceuticals
  20. 6.4.1 KPC Pharmaceuticals Company Information
  21. 6.4.2 KPC Pharmaceuticals Business Overview
  22. 6.4.3 KPC Pharmaceuticals Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 KPC Pharmaceuticals Antigout Drug Product Portfolio
  24. 6.4.5 KPC Pharmaceuticals Recent Developments
  25. 6.5 Rotamreddy
  26. 6.5.1 Rotamreddy Company Information
  27. 6.5.2 Rotamreddy Business Overview
  28. 6.5.3 Rotamreddy Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Rotamreddy Antigout Drug Product Portfolio
  30. 6.5.5 Rotamreddy Recent Developments
  31. 6.6 WanBang
  32. 6.6.1 WanBang Company Information
  33. 6.6.2 WanBang Business Overview
  34. 6.6.3 WanBang Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 WanBang Antigout Drug Product Portfolio
  36. 6.6.5 WanBang Recent Developments
  37. 6.7 Teijin Pharma
  38. 6.7.1 Teijin Pharma Company Information
  39. 6.7.2 Teijin Pharma Business Overview
  40. 6.7.3 Teijin Pharma Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teijin Pharma Antigout Drug Product Portfolio
  42. 6.7.5 Teijin Pharma Recent Developments
  43. 6.8 Jiangsu Hengrui Medicine
  44. 6.8.1 Jiangsu Hengrui Medicine Company Information
  45. 6.8.2 Jiangsu Hengrui Medicine Business Overview
  46. 6.8.3 Jiangsu Hengrui Medicine Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Hengrui Medicine Antigout Drug Product Portfolio
  48. 6.8.5 Jiangsu Hengrui Medicine Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Antigout Drug Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Antigout Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Antigout Drug Product Portfolio
  60. 6.10.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Antigout Drug Sales by Country
  2. 7.1.1 North America Antigout Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antigout Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Antigout Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antigout Drug Market Size by Country
  6. 7.2.1 North America Antigout Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antigout Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Antigout Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antigout Drug Sales by Country
  2. 8.1.1 Europe Antigout Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antigout Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Antigout Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antigout Drug Market Size by Country
  6. 8.2.1 Europe Antigout Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antigout Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antigout Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antigout Drug Sales by Country
  2. 9.1.1 Asia-Pacific Antigout Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antigout Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antigout Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antigout Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Antigout Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antigout Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antigout Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antigout Drug Sales by Country
  2. 10.1.1 South America Antigout Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antigout Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Antigout Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antigout Drug Market Size by Country
  6. 10.2.1 South America Antigout Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antigout Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Antigout Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antigout Drug Sales by Country
  2. 11.1.1 Middle East and Africa Antigout Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antigout Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antigout Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antigout Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Antigout Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antigout Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antigout Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antigout Drug Value Chain Analysis
  2. 12.1.1 Antigout Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antigout Drug Production Mode & Process
  7. 12.2 Antigout Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antigout Drug Distributors
  10. 12.2.3 Antigout Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research